Meta-analyses indicate that APOE ε4 carriers exhibit approximately twice the risk of developing delirium in patients following major surgery, particularly orthopedic and cardiac procedures, compared to non-carriers (pooled OR 1.89, 95% CI 1.36–2.62) [108]. This evidence concerns the gene APOE and delirium.